AAAAAA

   
Results: 1-15 |
Results: 15
A PHASE-II STUDY OF DAILY SUBCUTANEOUS (SQ) LOW-DOSE INTERLEUKIN-2 (IL-2) IN HIV-ASSOCIATED MALIGNANCIES
Authors: BERNSTEIN ZP BARRESI G GOULD M POIESZ B CALIGIURI MA
Citation: Zp. Bernstein et al., A PHASE-II STUDY OF DAILY SUBCUTANEOUS (SQ) LOW-DOSE INTERLEUKIN-2 (IL-2) IN HIV-ASSOCIATED MALIGNANCIES, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 96-96
CLINICAL SPECTRUM OF HTLV-I IN SOUTH FLORIDA
Authors: HARRINGTON WJ UCAR A GILL P SNODGRASS S SHEREMATA W CABRAL L RABIN M BYRNE GE BERGER J VOIGHT W KEMPER R MILLER G WHITCOMB CC GREENBERG A BYRNES JJ POIESZ B
Citation: Wj. Harrington et al., CLINICAL SPECTRUM OF HTLV-I IN SOUTH FLORIDA, Journal of acquired immune deficiency syndromes and human retrovirology, 8(5), 1995, pp. 466-473
HTLV-II IN SEMINOLES - ASSOCIATION WITH DISEASE
Authors: SHEREMATA WA LOWIS GW WICKHAM P TORRONI A POIESZ B
Citation: Wa. Sheremata et al., HTLV-II IN SEMINOLES - ASSOCIATION WITH DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 187-187
HUMAN HERPESVIRUS-LIKE NUCLEIC-ACID IN VARIOUS FORMS OF KAPOSIS-SARCOMA
Authors: HUANG YQ LI JJ KAPLAN MH POIESZ B KATABIRA E ZHANG WC FEINER D FRIEDMANKIEN AE
Citation: Yq. Huang et al., HUMAN HERPESVIRUS-LIKE NUCLEIC-ACID IN VARIOUS FORMS OF KAPOSIS-SARCOMA, Lancet, 345(8952), 1995, pp. 759-761
PROLONGED ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED MALIGNANCY RESULTS IN SELECTIVE EXPANSION OF INNATE IMMUNE EFFECTORS WITHOUT SIGNIFICANT CLINICAL TOXICITY
Authors: BERNSTEIN ZP PORTER MM GOULD M LIPMAN B BLUMAN EM STEWART CC HEWITT RG FYFE G POIESZ B CALIGIURI MA
Citation: Zp. Bernstein et al., PROLONGED ADMINISTRATION OF LOW-DOSE INTERLEUKIN-2 IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED MALIGNANCY RESULTS IN SELECTIVE EXPANSION OF INNATE IMMUNE EFFECTORS WITHOUT SIGNIFICANT CLINICAL TOXICITY, Blood, 86(9), 1995, pp. 3287-3294
THE PHYLOGENY OF THE PRIMATE T-CELL LYMPHOMA LEUKEMIA VIRUSES/
Authors: POIESZ B DUBE S SHERMAN M SAKSENA N DUBE D LOVE J
Citation: B. Poiesz et al., THE PHYLOGENY OF THE PRIMATE T-CELL LYMPHOMA LEUKEMIA VIRUSES/, AIDS research and human retroviruses, 10(4), 1994, pp. 449-449
EXPERIMENTAL INTRASPECIES TRANSMISSION OF STLV-I INTO NONHUMAN-PRIMATES
Authors: SAKSENA N HERVE V DURAND J MATHIOT C LOVE J SAKSENA M BARRESINOUSSI F POIESZ B
Citation: N. Saksena et al., EXPERIMENTAL INTRASPECIES TRANSMISSION OF STLV-I INTO NONHUMAN-PRIMATES, AIDS research and human retroviruses, 10(4), 1994, pp. 458-458
SERONEGATIVE HTLV-I PCR POSITIVE PATIENTS WITH CD4+ LYMPHOMAS
Authors: DEAN T PLUMAS N RENSHAW G SHERMAN M SAKSENA N AMIN R DUBE S HUTCHISON R BARRESINOUSSI F POIESZ B
Citation: T. Dean et al., SERONEGATIVE HTLV-I PCR POSITIVE PATIENTS WITH CD4+ LYMPHOMAS, AIDS research and human retroviruses, 10(4), 1994, pp. 469-469
CUTANEOUS T-CELL LYMPHOMA IN A PATIENT COINFECTED WITH HTLV-II AND HIV-1
Authors: BRYZGORNIA V BUSHUNOW P AMIN R HUTCHINSON B DUBE D POIESZ B
Citation: V. Bryzgornia et al., CUTANEOUS T-CELL LYMPHOMA IN A PATIENT COINFECTED WITH HTLV-II AND HIV-1, AIDS research and human retroviruses, 10(4), 1994, pp. 474-474
SEQUENCE-ANALYSIS OF A STLV-I ISOLATE FROM A NATURALLY INFECTED TANTALUS MONKEY
Authors: LOVE J SAKSENA N DUBE S HERVE V BARRESINOUSSI F POIESZ B
Citation: J. Love et al., SEQUENCE-ANALYSIS OF A STLV-I ISOLATE FROM A NATURALLY INFECTED TANTALUS MONKEY, AIDS research and human retroviruses, 10(4), 1994, pp. 504-504
RETROVIRUSES AND CANCER - US-JAPAN CLINICO-EPIDEMIOLOGIC EXPERIENCES HELD UNDER THE AUSPICES OF THE US-JAPAN BILATERAL AGREEMENT
Authors: BRODER S MILLER RW HINO S BLATTNER WA YOSHIDA M ROSENBLATT J BRADY J FRANCHINI G TAJIMA K MUELLER N TAKATSUKI K WALDMANN T WATANABE T MIYOSHI I POIESZ B SUGAMURA K SONODA S JACOBSON S BENVENISTE R YANAGIHARA R GALLO R
Citation: S. Broder et al., RETROVIRUSES AND CANCER - US-JAPAN CLINICO-EPIDEMIOLOGIC EXPERIENCES HELD UNDER THE AUSPICES OF THE US-JAPAN BILATERAL AGREEMENT, Leukemia, 8(4), 1994, pp. 694-704
DESIGN AND USE OF SIGNATURE PRIMERS TO DETECT CARRY-OVER OF AMPLIFIEDMATERIAL
Authors: ABBOTT LZ SPICER T BRYZGORNIA V KWOK S SNINSKY J POIESZ B
Citation: Lz. Abbott et al., DESIGN AND USE OF SIGNATURE PRIMERS TO DETECT CARRY-OVER OF AMPLIFIEDMATERIAL, Journal of virological methods, 46(1), 1994, pp. 51-59
PHASE-I STUDY OF DAILY SUBCUTANEOUS (SQ) LOW-DOSE INTERLEUKIN-2 (IL-2) IN HIV-ASSOCIATED MALIGNANCIES
Authors: BERNSTEIN ZP PORTER M GRIMES P GOULD M POIESZ B FYFE G CALIGIURI MA
Citation: Zp. Bernstein et al., PHASE-I STUDY OF DAILY SUBCUTANEOUS (SQ) LOW-DOSE INTERLEUKIN-2 (IL-2) IN HIV-ASSOCIATED MALIGNANCIES, Blood, 84(10), 1994, pp. 10000483-10000483
PROGRESSIVE NEMALINE ROD MYOPATHY IN A WOMAN COINFECTED WITH HIV-1 AND HTLV-2
Authors: MAYTAL J HOROWITZ S LIPPER S POIESZ B WANG CY SIEGAL FP
Citation: J. Maytal et al., PROGRESSIVE NEMALINE ROD MYOPATHY IN A WOMAN COINFECTED WITH HIV-1 AND HTLV-2, The Mount Sinai journal of medicine, 60(3), 1993, pp. 242-246
MODERATE HEMOPHILIA-B LEYDEN - IDENTIFICATION BY POLYMERASE CHAIN-REACTION, SEQUENCING AND OLIGOMER RESTRICTION
Authors: COYLE T SPICER T MICHALOVIC D POIESZ B
Citation: T. Coyle et al., MODERATE HEMOPHILIA-B LEYDEN - IDENTIFICATION BY POLYMERASE CHAIN-REACTION, SEQUENCING AND OLIGOMER RESTRICTION, Clinical research, 41(3), 1993, pp. 10000601-10000601
Risultati: 1-15 |